Malta - English - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - cream - fluorouracil 5 % (w/w) - antineoplastic agents

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - decitabine - powder for concentrate for solution for infusion - decitabine 50 mg - decitabine - decitabine trima is indicated for treatment of patients with myelodysplastic syndromes (mds) including previously treated and untreated, de novo and secondary mds of all french-american-british subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2 and high-risk international prognostic scoring system groups. decitabine trima is indicated for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia (aml), according to the world health organisation (who) classification, who are not candidates for standard induction chemotherapy

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - powder for suspension for injection - azacitidine 25 mg/ml - antineoplastic agents

Israel - English - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - lyophilic powder for concentrated infusion - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Israel - English - Ministry of Health

eli lilly israel ltd - gemcitabine as hydrochloride - lyophilic powder for concentrated infusion - gemcitabine as hydrochloride 1 g/vial - pyrimidine analogues - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - cytarabine - solution for injection/infusion - 100 milligram(s)/millilitre - pyrimidine analogues; cytarabine

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - gemcitabine - powder for solution for infusion - 1 gram(s) - pyrimidine analogues; gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - gemcitabine hydrochloride - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 200 milligram(s) - pyrimidine analogues; gemcitabine